Patients For Affordable Drugs Asks the Federal Trade Commission to Investigate.
It’s time for patients and taxpayers to stop subsidizing the marketing budgets of drug corporations and start seeing lower prices.
Who’s funding this group anyway?
STATEMENT: Patients Respond To Drug Company Executive Who Claims A ‘Moral Requirement’ To Raise Antibiotic Price By 400 Percent
Mulye said he has a ‘moral requirement’ to make money where he can and compared his decision to increase the price to that of an art dealer who sells ‘a painting for half a million dollars.’